Heart failure is characterized by pathologic hemodynamic derangements, including elevated
cardiac filling pressures (“backward” failure), which may or may not coexist with reduced …

Pulmonary hypertension (PH) associated with left heart disease, or Group 2 PH, includes
heart failure, valvular heart diseases, and congenital heart diseases. Although it is axiomatic …

Patients with heart failure with preserved ejection fraction (HFpEF) universally complain of
exercise intolerance and dyspnoea as key clinical correlates. Cardiac as well as …

Abstract Purpose of Review Heart failure with preserved ejection fraction (HFpEF) is a
relatively new disease entity used in medical terminology; however, both the number of …

Beta-blocker (BB) therapy is a main pillar in treating patients with heart failure and reduced
ejection fraction and has shown a prognostic benefit. However, evidence for application of …

Medical data analysis is being recognized as a field of enormous research possibilities due
to the fact there is a huge amount of data available and prediction in initial stage may save …

Aims Pathophysiological mechanisms behind cardio-pulmonary impairment in heart failure
(HF) with reduced (HFrEF) and preserved (HFpEF) ejection fraction are likely different. We …

Objectives Heart failure with mildly reduced ejection fraction (HFmrEF) or heart failure with
preserved ejection fraction (HFpEF) are associated with significant morbidity and mortality …

Whilst heart failure with preserved ejection fraction (HFpEF) is increasingly studied, the
search for a single pharmacotherapeutic agent that will improve hard endpoints like …

Aim Left atrial (LA) myopathy is increasingly recognized as an important phenotypic trait in
heart failure (HF) with preserved ejection fraction (HFpEF). Right atrial (RA) remodelling and …